NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,265,122 | +184.2% | 166,879 | +105.6% | 0.81% | +210.0% |
| Q4 2022 | $3,260,559 | -5.2% | 81,169 | +3.5% | 0.26% | -10.6% |
| Q3 2022 | $3,438,000 | +5.5% | 78,451 | -14.7% | 0.29% | +5.8% |
| Q2 2022 | $3,259,000 | -59.7% | 91,949 | -53.8% | 0.28% | -56.5% |
| Q1 2022 | $8,088,000 | -62.8% | 198,824 | -14.7% | 0.63% | -54.4% |
| Q4 2021 | $21,771,000 | -8.5% | 233,117 | +9.2% | 1.39% | -5.9% |
| Q3 2021 | $23,781,000 | -10.3% | 213,400 | -8.6% | 1.48% | +9.9% |
| Q2 2021 | $26,506,000 | +59.9% | 233,468 | +43.0% | 1.34% | +22.2% |
| Q1 2021 | $16,579,000 | – | 163,278 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |